Cao Yi, Jiang Zhelong, Wang Shaohu, Zhang Haoyang, Jiang Yi, Lv Lizhi
Department of Hepatobiliary Surgery, Fuzhou General Hospital (Dongfang Hospital), Fuzhou, Fujian 350025, P.R. China.
Department of Hepatobiliary Surgery Fuzong Clinical College of Fujian Medical University, Fuzhou, Fujian 350004, P.R. China.
Oncol Lett. 2018 Feb;15(2):2574-2582. doi: 10.3892/ol.2017.7612. Epub 2017 Dec 13.
The present study developed a novel laboratory-based algorithm to predict long-term survival rates in patients undergoing curative resection for solitary hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC). The present study included 426 patients with solitary HBV-related HCC who underwent surgery for primary tumors at a single center between 2003 and 2012. Demographic characteristics, laboratory analysis, clinical pathology and immunohistochemistry of topoisomerase II-a and Ki67 were analyzed. A simple prognostic risk calculator was developed using regression coefficients from multivariate models. A prognostic risk calculator incorporating tumor encapsulation, neutrophil-to-lymphocyte ratio, vascular invasion, α-fetoprotein level, Edmondson-Steiner classification, Topo II-α, prognostic nutritional index and Child-Pugh grade was constructed. The prognostic model demonstrated good discrimination with a C-index prior to adjustment of 0.81 (95% confidence interval: 0.78-0.84) and a bootstrap-corrected C-index of 0.81. Kaplan-Meier curves demonstrated that the probabilities of overall survival rates in the low-risk group were increased compared with those in the high-risk group. The areas under the receiver operating characteristic curve using the method were greater compared with those under the 7th Tumor-Node-Metastasis system and Cancer of the Liver Italian Program scoring system [0.83 vs. 0.62 and 0.77 (P<0.001), respectively]. The simple prognostic model of the present study accurately predicted survival rates in patients. Such a prognostic risk calculator for staging patients undergoing curative resection for solitary HBV-related HCC facilitates clinical surveillance and therapy.
本研究开发了一种基于实验室的新型算法,以预测接受根治性切除的孤立性乙型肝炎病毒(HBV)相关肝细胞癌(HCC)患者的长期生存率。本研究纳入了426例2003年至2012年间在单一中心接受原发性肿瘤手术的孤立性HBV相关HCC患者。分析了人口统计学特征、实验室分析、临床病理以及拓扑异构酶II-α和Ki67的免疫组化情况。利用多变量模型的回归系数开发了一个简单的预后风险计算器。构建了一个包含肿瘤包膜、中性粒细胞与淋巴细胞比值、血管侵犯、甲胎蛋白水平、Edmondson-Steiner分级、拓扑异构酶II-α、预后营养指数和Child-Pugh分级的预后风险计算器。该预后模型在调整前的C指数为0.81(95%置信区间:0.78 - 0.84),经自抽样校正后的C指数为0.81,显示出良好的区分度。Kaplan-Meier曲线表明,低风险组的总生存率概率高于高风险组。使用该方法得到的受试者工作特征曲线下面积大于第七版肿瘤-淋巴结-转移系统和意大利肝癌项目评分系统下的面积[分别为0.83对0.62和0.77(P<0.001)]。本研究的简单预后模型准确预测了患者的生存率。这种用于对接受根治性切除的孤立性HBV相关HCC患者进行分期的预后风险计算器有助于临床监测和治疗。